Results 41 to 50 of about 8,097,471 (281)
Rapamycin Reverses Pulmonary Artery Smooth Muscle Cell Proliferation in Pulmonary Hypertension
Abstract Pulmonary artery (PA) smooth muscle cell (SMC) proliferation in pulmonary hypertension (PH) may be linked to dysregulated mammalian target of rapamycin (mTOR) signaling. The mTOR pathway involves two independent complexes, mTORC1 and mTORC2, which phosphorylate S6 kinase (S6K) and serine/threonine kinase (Akt), respectively ...
Amal, Houssaini +10 more
openaire +3 more sources
BackgroundEarlier, we reported that the simultaneous exposure of pulmonary arterial smooth muscle cells to HIV proteins and cocaine results in the attenuation of antiproliferative bone morphogenetic protein receptor‐2 (BMPR2) protein expression without ...
Mahendran Chinnappan +4 more
doaj +1 more source
Free radical production in hypoxic pulmonary artery smooth muscle cells [PDF]
This study used an inexpensive and versatile environmental exposure system to test the hypothesis that hypoxia promoted free radical production in primary cultures of rat main pulmonary artery smooth muscle cells (PASMCs). Production of reactive species was detected by fluorescence microscopy with the probe 2′,7′-dichlorodihydrofluorescein, which is ...
D W, Killilea +4 more
openaire +2 more sources
Mir-206 regulates pulmonary artery smooth muscle cell proliferation and differentiation. [PDF]
Pulmonary Arterial Hypertension (PAH) is a progressive devastating disease characterized by excessive proliferation of the Pulmonary Arterial Smooth Muscle Cells (PASMCs).
Samuel Jalali +9 more
doaj +1 more source
Abstract Aims Orchestrating the transition from reversible medial hypertrophy to irreversible plexiform lesions is crucial for pulmonary arterial hypertension related to congenital heart disease (CHD-PAH).
Jing‐jing Zhou +12 more
openaire +3 more sources
Transcription factors and potential therapeutic targets for pulmonary hypertension
Pulmonary hypertension (PH) is a refractory and fatal disease characterized by excessive pulmonary arterial cell remodeling. Uncontrolled proliferation and hypertrophy of pulmonary arterial smooth muscle cells (PASMCs), dysfunction of pulmonary arterial ...
Liu Yang +5 more
doaj +1 more source
Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice [PDF]
Pulmonary hypertension is a significant cause of morbidity and mortality in infants. Historically, there has been significant study of the signaling pathways involved in vascular smooth muscle contraction in PASMC from fetal sheep. While sheep make an excellent model of term pulmonary hypertension, they are very expensive and lack the advantage of ...
Keng Jin, Lee +3 more
openaire +2 more sources
Pulmonary arterial remodeling at an early stage, including excessive proliferation and migration of smooth muscle cells, is a hallmark of pulmonary arterial hypertension (PAH).
Jiangqin Pu +6 more
doaj +1 more source
Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension [PDF]
Pulmonary arterial hypertension (PAH) results from persistent vasoconstriction, smooth muscle growth and extracellular matrix (ECM) remodelling of pulmonary arteries (PAs). Matrix metalloproteinases (MMPs) are matrix-degrading enzymes involved in ECM turnover, and in smooth muscle cell (SMC) and endothelial cell migration and proliferation.
Lepetit, H. +9 more
openaire +3 more sources
Impact of TASK-1 in Human Pulmonary Artery Smooth Muscle Cells [PDF]
The excitability of pulmonary artery smooth muscle cells (PASMC) is regulated by potassium (K + ) conductances. Although studies suggest that background K + currents carried by 2-pore domain K + channels are important regulators of resting membrane potential in PASMC ...
Andrea, Olschewski +13 more
openaire +2 more sources

